Top Markets
Coin of the day
General Biologicals Corporation General Biologicals Corporation

General Biologicals Corporation

4117
Pozycja w akcjach #29236
General Biologicals Corporation (GBC) is a company dedicated to the research,... General Biologicals Corporation (GBC) is a company dedicated to the research, development, production, and global commercialization of in-vitro diagnostic (IVD) solutions, operating extensively both within Taiwan and internationally. The company's core diagnostic offerings include advanced ELISA and chemiluminescence immunoassays, molecular and cellular diagnostic platforms, and rapid point-of-care testing (POCT) systems. Its diverse portfolio further encompasses COVID-19 related solutions, digital pathology, and contract development manufacturing organization (CDMO) services. Additionally, GBC provides essential blood screening services for detecting hepatitis and HIV, alongside crucial biomaterials such as antibody preparations and human plasma. Venturing beyond diagnostics, the company also markets a line of oral care products under its proprietary 'oh care' brand. These diagnostic systems are primarily utilized by clinics and laboratories. Founded in 1973, General Biologicals Corporation is headquartered in Hsinchu City, Taiwan.
Cena akcji
$0.31640033
Kapitalizacja rynkowa
$22.25M
Zmiana (1 dzień)
-3.40%
Zmiana (1 rok)
-36.80%
Kraj
TW
Handel General Biologicals Corporation (4117)

Kategoria

Cena 4117 z kapitalizacją rynkową B
General Biologicals Corporation General Biologicals Corporation
4117
$0.31640033
Kapitalizacja rynkowa General Biologicals Corporation(4117)
Kapitalizacja rynkowa: $22.25M
Na dzień August 2026 spółka General Biologicals Corporation ma kapitalizację rynkową wynoszącą $22.25M. Według naszych danych, czyni to General Biologicals Corporation 29236th najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej General Biologicals Corporation od 2007 do 2026
4117 w porównaniu do 5 najpopularniejszych stocks
Cena za 4117 Aktywa B Kapitalizacja rynkowa B Wyniki
General Biologicals Corporation General Biologicals Corporation
$75,496.46 $22.25M
$5.309T +23,860,955.59%
General Biologicals Corporation General Biologicals Corporation
$66,280.07 $22.25M
$4.661T +20,948,065.96%
General Biologicals Corporation General Biologicals Corporation
$59,088.07 $22.25M
$4.155T +18,674,997.25%
General Biologicals Corporation General Biologicals Corporation
$51,150.94 $22.25M
$3.597T +16,166,425.67%
General Biologicals Corporation General Biologicals Corporation
$40,457.44 $22.25M
$2.845T +12,786,688.61%